Identifying the low-risk population for metachronous colorectal neoplasia: a first step towards personalized surveillance

Endoscopy 2020; 52(03): 172-173
DOI: 10.1055/a-1070-9226

Editorial

Referring to Frazzoni L et al. p. 220–226

Jae Gon Lee

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

,

Dong Soo Han

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

References
1 Torre LA, Bray F, Siegel RL. et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108
2 Mulder SA, Kranse R, Damhuis RA. et al. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up. Dis Colon Rectum 2012; 55: 522-531
3 Hassan C, Wysocki PT, Fuccio L. et al. Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline. Endoscopy 2019; 51: 266-277
4 Kahi CJ, Boland CR, Dominitz JA. et al. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2016; 150: 758-768.e11
5 Fuccio L, Rex D, Ponchon T. et al. New and recurrent colorectal cancers after resection: a systematic review and meta-analysis of endoscopic surveillance studies. Gastroenterology 2019; 156: 1309-1323.e3
6 Frazzoni L, Laterza L, Mussetto A. et al. How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: a predictive model. Endoscopy 2020; 52: 220-226
7 Rutter MD, Beintaris I, Valori R. et al. World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology 2018; 155: 909-925.e3